Collegium Pharmaceutical Inc at Needham Healthcare Conference Transcript
Hi, good afternoon. I am Serge Belanger, one of the healthcare analysts at Needham. Thanks for dialing in or logging in to the 19th Annual Needham Conference. For our next session we have Collegium Pharmaceuticals. Paul Brannelly, the CFO, as well as Joe Ciaffoni, the CEO, are both with us to talk about Collegium. Gentlemen?
Great, thanks, Serge. Before we begin today's fireside chat we want to remind everyone that none of the information presented today is intended to be promotional and that any forward-looking statements made today are made pursuant to the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995.
You are cautioned that such forward-looking statements involve risks and uncertainties including and without limitation the risks that we may incur significant expense and may not prevail in current or future opioid industry litigation and investigations or other litigations pertaining to our products. These
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |